{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:56:55Z","timestamp":1787061415923,"version":"build-2736575974"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41582-026-01218-7","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:14:10Z","timestamp":1780478050000},"page":"439-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5769-183X","authenticated-orcid":false,"given":"G\u00fclin","family":"\u00d6z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0300-5160","authenticated-orcid":false,"given":"Sirio","family":"Cocozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-0313","authenticated-orcid":false,"given":"Thiago J. R.","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-1956","authenticated-orcid":false,"given":"Pierre-Gilles","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Ataxia Global Initiative Working Group on MRI Biomarkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore A.","family":"Accolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Adarmes-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud","family":"Alhusaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyota","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Boesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Cossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Deistung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"D\u2019Ostilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Marcondes C.","family":"Franca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccolo","family":"Fuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gazdzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Grisoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Indelicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Joers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Kapteijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi M.","family":"Kinnunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherie L.","family":"Marvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Minnerop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Mochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Moreira","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Nachbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nigri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Jorge","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan A.","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Ratai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Reetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Rylski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda M.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kastytis","family":"Sestakauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Thieme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Timmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00415-022-11383-6","volume":"270","author":"G Coarelli","year":"2023","unstructured":"Coarelli, G. et al. The inherited cerebellar ataxias: an update. J. Neurol. 270, 208\u2013222 (2023).","journal-title":"J. Neurol."},{"key":"1218_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s40263-024-01113-z","volume":"38","author":"V Scott","year":"2024","unstructured":"Scott, V., Delatycki, M. B., Tai, G. & Corben, L. A. New and emerging drug and gene therapies for Friedreich ataxia. CNS Drugs 38, 791\u2013805 (2024).","journal-title":"CNS Drugs"},{"key":"1218_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.molmed.2024.07.008","volume":"31","author":"MLS Eisel","year":"2025","unstructured":"Eisel, M. L. S. et al. Emerging therapies in hereditary ataxias. Trends Mol. Med. 31, 181\u2013194 (2025).","journal-title":"Trends Mol. Med."},{"key":"1218_CR4","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch, T. et al. Scale for the Assessment and Rating of Ataxia: development of a new clinical scale. Neurology 66, 1717\u20131720 (2006).","journal-title":"Neurology"},{"key":"1218_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","volume":"64","author":"SH Subramony","year":"2005","unstructured":"Subramony, S. H. et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology 64, 1261\u20131262 (2005).","journal-title":"Neurology"},{"key":"1218_CR6","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","volume":"14","author":"H Jacobi","year":"2015","unstructured":"Jacobi, H. et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol. 14, 1101\u20131108 (2015).","journal-title":"Lancet Neurol."},{"key":"1218_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S1474-4422(16)30287-3","volume":"15","author":"K Reetz","year":"2016","unstructured":"Reetz, K. et al. Progression characteristics of the European Friedreich\u2019s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. Lancet Neurol. 15, 1346\u20131354 (2016).","journal-title":"Lancet Neurol."},{"key":"1218_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","volume":"14","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa, T., \u00d6z, G. & Paulson, H. L. Spinocerebellar ataxias: prospects and challenges for therapy development. Nat. Rev. Neurol. 14, 590\u2013605 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1218_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s12311-023-01572-y","volume":"23","author":"G \u00d6z","year":"2024","unstructured":"\u00d6z, G. et al. MR imaging in ataxias: consensus recommendations by the Ataxia Global Initiative working group on MRI biomarkers. Cerebellum 23, 931\u2013945 (2024).","journal-title":"Cerebellum"},{"key":"1218_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s12311-023-01561-1","volume":"23","author":"FM Santorelli","year":"2024","unstructured":"Santorelli, F. M. et al. Standards of fluid biomarker collection and pre-analytical processes in humans and mice: recommendations by the Ataxia Global Initiative working group on biomarkers. Cerebellum 23, 881\u2013886 (2024).","journal-title":"Cerebellum"},{"key":"1218_CR11","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s12311-023-01625-2","volume":"23","author":"W Ilg","year":"2024","unstructured":"Ilg, W. et al. Quantitative gait and balance outcomes for ataxia trials: consensus recommendations by the Ataxia Global Initiative working group on digital-motor biomarkers. Cerebellum 23, 1566\u20131592 (2024).","journal-title":"Cerebellum"},{"key":"1218_CR12","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s13311-021-01027-4","volume":"18","author":"AJ Schwarz","year":"2021","unstructured":"Schwarz, A. J. The use, standardization, and interpretation of brain imaging data in clinical trials of neurodegenerative disorders. Neurotherapeutics 18, 686\u2013708 (2021).","journal-title":"Neurotherapeutics"},{"key":"1218_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/nbm.1062","volume":"19","author":"SG Mueller","year":"2006","unstructured":"Mueller, S. G., Schuff, N. & Weiner, M. W. Evaluation of treatment effects in Alzheimer\u2019s and other neurodegenerative diseases by MRI and MRS. NMR Biomed. 19, 655\u2013668 (2006).","journal-title":"NMR Biomed."},{"key":"1218_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.29032","volume":"37","author":"T Klockgether","year":"2022","unstructured":"Klockgether, T. et al. Paving the way toward meaningful trials in ataxias: an Ataxia Global Initiative perspective. Mov. Disord. 37, 1125\u20131130 (2022).","journal-title":"Mov. Disord."},{"key":"1218_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","volume":"4","author":"HT Orr","year":"1993","unstructured":"Orr, H. T. et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 4, 221\u2013226 (1993).","journal-title":"Nat. Genet."},{"key":"1218_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.conb.2021.07.001","volume":"72","author":"EL Bunting","year":"2022","unstructured":"Bunting, E. L., Hamilton, J. & Tabrizi, S. J. Polyglutamine diseases. Curr. Opin. Neurobiol. 72, 39\u201347 (2022).","journal-title":"Curr. Opin. Neurobiol."},{"key":"1218_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","volume":"104","author":"U Rub","year":"2013","unstructured":"Rub, U. et al. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog. Neurobiol. 104, 38\u201366 (2013).","journal-title":"Prog. Neurobiol."},{"key":"1218_CR18","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/brain\/121.9.1687","volume":"121","author":"T Klockgether","year":"1998","unstructured":"Klockgether, T. et al. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain 121, 1687\u20131693 (1998).","journal-title":"Brain"},{"key":"1218_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12311-008-0025-0","volume":"7","author":"S Dohlinger","year":"2008","unstructured":"Dohlinger, S., Hauser, T. K., Borkert, J., Luft, A. R. & Schulz, J. B. Magnetic resonance imaging in spinocerebellar ataxias. Cerebellum 7, 204\u2013214 (2008).","journal-title":"Cerebellum"},{"key":"1218_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neuroimage.2009.07.027","volume":"49","author":"JB Schulz","year":"2010","unstructured":"Schulz, J. B. et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage 49, 158\u2013168 (2010).","journal-title":"Neuroimage"},{"key":"1218_CR21","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s00415-018-9087-1","volume":"265","author":"CR Martins Junior","year":"2018","unstructured":"Martins Junior, C. R. et al. Structural signature in SCA1: clinical correlates, determinants and natural history. J. Neurol. 265, 2949\u20132959 (2018).","journal-title":"J. Neurol."},{"key":"1218_CR22","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s12311-024-01659-0","volume":"23","author":"M Ferreira","year":"2024","unstructured":"Ferreira, M. et al. Cerebellar volumetry in ataxias: relation to ataxia severity and duration. Cerebellum 23, 1521\u20131529 (2024).","journal-title":"Cerebellum"},{"key":"1218_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/mdc3.12804","volume":"6","author":"DK Deelchand","year":"2019","unstructured":"Deelchand, D. K. et al. Sensitivity of volumetric magnetic resonance imaging and magnetic resonance spectroscopy to progression of spinocerebellar ataxia type 1. Mov. Disord. Clin. Pract. 6, 549\u2013558 (2019).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1218_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ana.26573","volume":"93","author":"J Chandrasekaran","year":"2023","unstructured":"Chandrasekaran, J. et al. Clinically meaningful magnetic resonance endpoints sensitive to preataxic spinocerebellar ataxia types 1 and 3. Ann. Neurol. 93, 686\u2013701 (2023).","journal-title":"Ann. Neurol."},{"key":"1218_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s12311-017-0854-9","volume":"16","author":"CR Martins Jr","year":"2017","unstructured":"Martins, C. R. Jr et al. Spinal cord damage in spinocerebellar ataxia type 1. Cerebellum 16, 792\u2013796 (2017).","journal-title":"Cerebellum"},{"key":"1218_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/jnnp-2023-332696","volume":"95","author":"TJR Rezende","year":"2024","unstructured":"Rezende, T. J. R. et al. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study. J. Neurol. Neurosurg. Psychiatry 95, 682\u2013690 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1218_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/brain\/aws369","volume":"136","author":"K Reetz","year":"2013","unstructured":"Reetz, K. et al. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain 136, 905\u2013917 (2013).","journal-title":"Brain"},{"key":"1218_CR28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.nicl.2018.06.011","volume":"19","author":"IM Adanyeguh","year":"2018","unstructured":"Adanyeguh, I. M. et al. Autosomal dominant cerebellar ataxias: imaging biomarkers with high effect sizes. Neuroimage Clin. 19, 858\u2013867 (2018).","journal-title":"Neuroimage Clin."},{"key":"1218_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12311-021-01285-0","volume":"21","author":"A Nigri","year":"2022","unstructured":"Nigri, A. et al. Spinocerebellar ataxia type 1: one-year longitudinal study to identify clinical and MRI measures of disease progression in patients and presymptomatic carriers. Cerebellum 21, 133\u2013144 (2022).","journal-title":"Cerebellum"},{"key":"1218_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/ana.27032","volume":"96","author":"TH van Prooije","year":"2024","unstructured":"van Prooije, T. H. et al. Multimodal, longitudinal profiling of SCA1 identifies predictors of disease severity and progression. Ann. Neurol. 96, 774\u2013787 (2024).","journal-title":"Ann. Neurol."},{"key":"1218_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70325","author":"TJR Rezende","year":"2026","unstructured":"Rezende, T. J. R. et al. Value of MRI outcomes for preventive and early-stage trials in spinocerebellar ataxias 1 and 3. Ann. Clin. Transl. Neurol. https:\/\/doi.org\/10.1002\/acn3.70325 (2026).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1218_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fneur.2020.00411","volume":"11","author":"YW Park","year":"2020","unstructured":"Park, Y. W. et al. Assessment of cerebral and cerebellar white matter microstructure in spinocerebellar ataxias 1, 2, 3, and 6 using diffusion MRI. Front. Neurol. 11, 411 (2020).","journal-title":"Front. Neurol."},{"key":"1218_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/ana.25212","volume":"83","author":"JM Joers","year":"2018","unstructured":"Joers, J. M. et al. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias. Ann. Neurol. 83, 816\u2013829 (2018).","journal-title":"Ann. Neurol."},{"key":"1218_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/mds.26181","volume":"30","author":"IM Adanyeguh","year":"2015","unstructured":"Adanyeguh, I. M. et al. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov. Disord. 30, 662\u2013670 (2015).","journal-title":"Mov. Disord."},{"key":"1218_CR35","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/mds.29934","volume":"39","author":"TJR Rezende","year":"2024","unstructured":"Rezende, T. J. R. et al. Sensitivity of advanced magnetic resonance imaging to progression over six months in early spinocerebellar ataxia. Mov. Disord. 39, 1856\u20131867 (2024).","journal-title":"Mov. Disord."},{"key":"1218_CR36","doi-asserted-by":"publisher","first-page":"107078","DOI":"10.1016\/j.nbd.2025.107078","volume":"215","author":"TH van Prooije","year":"2025","unstructured":"van Prooije, T. H. et al. The predictive validity of pontine volume change in spinocerebellar ataxia type 1 (SCA1). Neurobiol. Dis. 215, 107078 (2025).","journal-title":"Neurobiol. Dis."},{"key":"1218_CR37","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/brain\/awaf408","volume":"149","author":"E Petit","year":"2025","unstructured":"Petit, E. et al. Predictive models for ataxia progression and conversion in spinocerebellar ataxia type 1 and 3. Brain\u00a0149,\u00a01268\u20131277\u00a0(2025).","journal-title":"Brain"},{"key":"1218_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s004010050989","volume":"97","author":"R Estrada","year":"1999","unstructured":"Estrada, R., Galarraga, J., Orozco, G., Nodarse, A. & Auburger, G. Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol. 97, 306\u2013310 (1999).","journal-title":"Acta Neuropathol."},{"key":"1218_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00401-005-1014-8","volume":"109","author":"K Gierga","year":"2005","unstructured":"Gierga, K. et al. Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol. 109, 617\u2013631 (2005).","journal-title":"Acta Neuropathol."},{"key":"1218_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2990.2007.00933.x","volume":"34","author":"F Hoche","year":"2008","unstructured":"Hoche, F. et al. Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7). Neuropathol. Appl. Neurobiol. 34, 479\u2013491 (2008).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1218_CR41","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/brain\/awf060","volume":"125","author":"JT Pang","year":"2002","unstructured":"Pang, J. T. et al. Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. Brain 125, 656\u2013663 (2002).","journal-title":"Brain"},{"key":"1218_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.brainresrev.2006.08.003","volume":"53","author":"U Rub","year":"2007","unstructured":"Rub, U. et al. Consistent affection of the central somatosensory system in spinocerebellar ataxia type 2 and type 3 and its significance for clinical symptoms and rehabilitative therapy. Brain Res. Rev. 53, 235\u2013249 (2007).","journal-title":"Brain Res. Rev."},{"key":"1218_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/acn3.504","volume":"5","author":"K Reetz","year":"2018","unstructured":"Reetz, K. et al. Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2. Ann. Clin. Transl. Neurol. 5, 128\u2013137 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1218_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/mds.30143","volume":"40","author":"JW Robertson","year":"2025","unstructured":"Robertson, J. W. et al. The pattern and stages of atrophy in spinocerebellar ataxia type 2: volumetrics from ENIGMA-Ataxia. Mov. Disord. 40, 651\u2013661 (2025).","journal-title":"Mov. Disord."},{"key":"1218_CR45","doi-asserted-by":"publisher","first-page":"616419","DOI":"10.3389\/fneur.2020.616419","volume":"11","author":"A Nigri","year":"2020","unstructured":"Nigri, A. et al. Progression of cerebellar atrophy in spinocerebellar ataxia type 2 gene carriers: a longitudinal MRI study in preclinical and early disease stages. Front. Neurol. 11, 616419 (2020).","journal-title":"Front. Neurol."},{"key":"1218_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089410","volume":"9","author":"M Mascalchi","year":"2014","unstructured":"Mascalchi, M. et al. Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study. PLoS ONE 9, e89410 (2014).","journal-title":"PLoS ONE"},{"key":"1218_CR47","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209749","volume":"103","author":"G Coarelli","year":"2024","unstructured":"Coarelli, G. et al. Longitudinal changes of clinical, imaging, and fluid biomarkers in preataxic and early ataxic spinocerebellar ataxia type 2 and 7 carriers. Neurology 103, e209749 (2024).","journal-title":"Neurology"},{"key":"1218_CR48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12311-010-0213-6","volume":"10","author":"G \u00d6z","year":"2011","unstructured":"\u00d6z, G. et al. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum 10, 208\u2013217 (2011).","journal-title":"Cerebellum"},{"key":"1218_CR49","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/brain\/awh201","volume":"127","author":"L Guerrini","year":"2004","unstructured":"Guerrini, L. et al. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain 127, 1785\u20131795 (2004).","journal-title":"Brain"},{"key":"1218_CR50","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano, L., Melo, C., Silva, M. C. & Coutinho, P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42, 174\u2013183 (2014).","journal-title":"Neuroepidemiology"},{"key":"1218_CR51","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/archneur.58.6.899","volume":"58","author":"LB Jardim","year":"2001","unstructured":"Jardim, L. B. et al. Neurologic findings in Machado\u2013Joseph disease: relation with disease duration, subtypes, and (CAG)n. Arch. Neurol. 58, 899\u2013904 (2001).","journal-title":"Arch. Neurol."},{"key":"1218_CR52","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/archneur.57.10.1495","volume":"57","author":"L Schols","year":"2000","unstructured":"Schols, L. et al. Extrapyramidal motor signs in degenerative ataxias. Arch. Neurol. 57, 1495\u20131500 (2000).","journal-title":"Arch. Neurol."},{"key":"1218_CR53","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/mds.23584","volume":"26","author":"J van Gaalen","year":"2011","unstructured":"van Gaalen, J., Giunti, P. & van de Warrenburg, B. P. Movement disorders in spinocerebellar ataxias. Mov. Disord. 26, 792\u2013800 (2011).","journal-title":"Mov. Disord."},{"key":"1218_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ana.25297","volume":"84","author":"TJR Rezende","year":"2018","unstructured":"Rezende, T. J. R. et al. Structural signature of SCA3: from presymptomatic to late disease stages. Ann. Neurol. 84, 401\u2013408 (2018).","journal-title":"Ann. Neurol."},{"key":"1218_CR55","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1002\/mds.28610","volume":"36","author":"J Faber","year":"2021","unstructured":"Faber, J. et al. Regional brain and spinal cord volume loss in spinocerebellar ataxia type 3. Mov. Disord. 36, 2273\u20132281 (2021).","journal-title":"Mov. Disord."},{"key":"1218_CR56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/ene.12559","volume":"22","author":"TJ de Rezende","year":"2015","unstructured":"de Rezende, T. J. et al. Cerebral cortex involvement in Machado\u2013Joseph disease. Eur. J. Neurol. 22, 277\u2013283.e23\u201324 (2015).","journal-title":"Eur. J. Neurol."},{"key":"1218_CR57","doi-asserted-by":"publisher","first-page":"101339","DOI":"10.1016\/j.lanepe.2025.101339","volume":"55","author":"M Berger","year":"2025","unstructured":"Berger, M. et al. Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohort. Lancet Reg. Health Eur. 55, 101339 (2025).","journal-title":"Lancet Reg. Health Eur."},{"key":"1218_CR58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00415-024-12791-6","volume":"272","author":"FC de Borba","year":"2024","unstructured":"de Borba, F. C. et al. Tract-specific spinal damage in SCA2, SCA3 and SCA6. J. Neurol. 272, 6 (2024).","journal-title":"J. Neurol."},{"key":"1218_CR59","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/mds.28113","volume":"35","author":"CC Piccinin","year":"2020","unstructured":"Piccinin, C. C. et al. A 5-year longitudinal clinical and magnetic resonance imaging study in spinocerebellar ataxia type 3. Mov. Disord. 35, 1679\u20131684 (2020).","journal-title":"Mov. Disord."},{"key":"1218_CR60","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1007\/s00415-023-11763-6","volume":"270","author":"CM de Oliveira","year":"2023","unstructured":"de Oliveira, C. M. et al. The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3\/MJD. J. Neurol. 270, 4276\u20134287 (2023).","journal-title":"J. Neurol."},{"key":"1218_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuroscience.2024.12.055","volume":"567","author":"J Tang","year":"2025","unstructured":"Tang, J. et al. White matter functional and structural alterations of spinocerebellar ataxia type 3: a longitudinal MRI study. Neuroscience 567, 77\u201385 (2025).","journal-title":"Neuroscience"},{"key":"1218_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70127","volume":"32","author":"H Qiu","year":"2025","unstructured":"Qiu, H. et al. Altered brain iron depositions of spinocerebellar ataxia type 3: from pre-symptomatic to symptomatic stage. Eur. J. Neurol. 32, e70127 (2025).","journal-title":"Eur. J. Neurol."},{"key":"1218_CR63","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/acn3.70116","volume":"12","author":"DJ Arpin","year":"2025","unstructured":"Arpin, D. J. et al. Fixel-based analysis of diffusion imaging as a quantitative marker of disease state in spinocerebellar ataxia. Ann. Clin. Transl. Neurol. 12, 1846\u20131857 (2025).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1218_CR64","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1523\/JNEUROSCI.1954-20.2021","volume":"42","author":"KH Schuster","year":"2022","unstructured":"Schuster, K. H. et al. Impaired oligodendrocyte maturation is an early feature in SCA3 disease pathogenesis. J. Neurosci. 42, 1604\u20131617 (2022).","journal-title":"J. Neurosci."},{"key":"1218_CR65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.26824","volume":"95","author":"J Faber","year":"2024","unstructured":"Faber, J. et al. Stage-dependent biomarker changes in spinocerebellar ataxia type 3. Ann. Neurol. 95, 400\u2013406 (2024).","journal-title":"Ann. Neurol."},{"key":"1218_CR66","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.parkreldis.2015.10.016","volume":"21","author":"MB Nunes","year":"2015","unstructured":"Nunes, M. B. et al. Dystonia in Machado\u2013Joseph disease: clinical profile, therapy and anatomical basis. Parkinsonism Relat. Disord. 21, 1441\u20131447 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1218_CR67","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/jmedgenet-2013-102200","volume":"51","author":"S Tezenas du Montcel","year":"2014","unstructured":"Tezenas du Montcel, S. et al. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J. Med. Genet. 51, 479\u2013486 (2014).","journal-title":"J. Med. Genet."},{"key":"1218_CR68","doi-asserted-by":"publisher","first-page":"e2885","DOI":"10.1212\/WNL.0000000000012068","volume":"96","author":"L Peng","year":"2021","unstructured":"Peng, L. et al. New model for estimation of the age at onset in spinocerebellar ataxia type 3. Neurology 96, e2885\u2013e2895 (2021).","journal-title":"Neurology"},{"key":"1218_CR69","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A Durr","year":"1996","unstructured":"Durr, A. et al. Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia. N. Engl. J. Med. 335, 1169\u20131175 (1996).","journal-title":"N. Engl. J. Med."},{"key":"1218_CR70","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano, V. et al. Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423\u20131427 (1996).","journal-title":"Science"},{"key":"1218_CR71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jnen\/nlx087","volume":"76","author":"AH Koeppen","year":"2017","unstructured":"Koeppen, A. H., Becker, A. B., Qian, J. & Feustel, P. J. Friedreich ataxia: hypoplasia of spinal cord and dorsal root ganglia. J. Neuropathol. Exp. Neurol. 76, 101\u2013108 (2017).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1218_CR72","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1001\/archneur.65.10.1296","volume":"65","author":"M Pandolfo","year":"2008","unstructured":"Pandolfo, M. Friedreich ataxia. Arch. Neurol. 65, 1296\u20131303 (2008).","journal-title":"Arch. Neurol."},{"key":"1218_CR73","doi-asserted-by":"publisher","first-page":"fcad196","DOI":"10.1093\/braincomms\/fcad196","volume":"5","author":"IM Adanyeguh","year":"2023","unstructured":"Adanyeguh, I. M. et al. Brain MRI detects early-stage alterations and disease progression in Friedreich ataxia. Brain Commun. 5, fcad196 (2023).","journal-title":"Brain Commun."},{"key":"1218_CR74","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ana.26200","volume":"90","author":"IH Harding","year":"2021","unstructured":"Harding, I. H. et al. Brain structure and degeneration staging in Friedreich ataxia: magnetic resonance imaging volumetrics from the ENIGMA-Ataxia working group. Ann. Neurol. 90, 570\u2013583 (2021).","journal-title":"Ann. Neurol."},{"key":"1218_CR75","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1212\/WNL.46.1.118","volume":"46","author":"T Klockgether","year":"1996","unstructured":"Klockgether, T. et al. Friedreich\u2019s ataxia with retained tendon reflexes: molecular genetics, clinical neurophysiology, and magnetic resonance imaging. Neurology 46, 118\u2013121 (1996).","journal-title":"Neurology"},{"key":"1218_CR76","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2214\/ajr.163.1.8010211","volume":"163","author":"M Mascalchi","year":"1994","unstructured":"Mascalchi, M., Salvi, F., Piacentini, S. & Bartolozzi, C. Friedreich\u2019s ataxia: MR findings involving the cervical portion of the spinal cord. AJR Am. J. Roentgenol. 163, 187\u2013191 (1994).","journal-title":"AJR Am. J. Roentgenol."},{"key":"1218_CR77","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12311-010-0232-3","volume":"10","author":"H Akhlaghi","year":"2011","unstructured":"Akhlaghi, H. et al. Superior cerebellar peduncle atrophy in Friedreich\u2019s ataxia correlates with disease symptoms. Cerebellum 10, 81\u201387 (2011).","journal-title":"Cerebellum"},{"key":"1218_CR78","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12311-012-0390-6","volume":"12","author":"CF Chevis","year":"2013","unstructured":"Chevis, C. F. et al. Spinal cord atrophy correlates with disability in Friedreich\u2019s ataxia. Cerebellum 12, 43\u201347 (2013).","journal-title":"Cerebellum"},{"key":"1218_CR79","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/jnnp-2018-318422","volume":"90","author":"I Dogan","year":"2019","unstructured":"Dogan, I. et al. Structural characteristics of the central nervous system in Friedreich ataxia: an in vivo spinal cord and brain MRI study. J. Neurol. Neurosurg. Psychiatry 90, 615\u2013617 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1218_CR80","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/mds.28841","volume":"37","author":"A Hernandez","year":"2022","unstructured":"Hernandez, A., Rezende, T. J. R., Martinez, A. R. M., de Brito, M. R. & Franca, M. C. Jr. Tract-specific spinal cord diffusion tensor imaging in Friedreich\u2019s ataxia. Mov. Disord. 37, 354\u2013364 (2022).","journal-title":"Mov. Disord."},{"key":"1218_CR81","doi-asserted-by":"publisher","first-page":"fcac246","DOI":"10.1093\/braincomms\/fcac246","volume":"4","author":"JM Joers","year":"2022","unstructured":"Joers, J. M. et al. Spinal cord magnetic resonance imaging and spectroscopy detect early-stage alterations and disease progression in Friedreich ataxia. Brain Commun. 4, fcac246 (2022).","journal-title":"Brain Commun."},{"key":"1218_CR82","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mds.26436","volume":"31","author":"TJ Rezende","year":"2016","unstructured":"Rezende, T. J. et al. Longitudinal magnetic resonance imaging study shows progressive pyramidal and callosal damage in Friedreich\u2019s ataxia. Mov. Disord. 31, 70\u201378 (2016).","journal-title":"Mov. Disord."},{"key":"1218_CR83","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/hbm.24921","volume":"41","author":"LP Selvadurai","year":"2020","unstructured":"Selvadurai, L. P. et al. Multiple mechanisms underpin cerebral and cerebellar white matter deficits in Friedreich ataxia: the IMAGE-FRDA study. Hum. Brain Mapp. 41, 1920\u20131933 (2020).","journal-title":"Hum. Brain Mapp."},{"key":"1218_CR84","doi-asserted-by":"publisher","first-page":"fcab306","DOI":"10.1093\/braincomms\/fcab306","volume":"4","author":"A Deistung","year":"2022","unstructured":"Deistung, A. et al. Quantitative susceptibility mapping reveals alterations of dentate nuclei in common types of degenerative cerebellar ataxias. Brain Commun. 4, fcab306 (2022).","journal-title":"Brain Commun."},{"key":"1218_CR85","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/jnr.24701","volume":"98","author":"S Straub","year":"2020","unstructured":"Straub, S. et al. Toward quantitative neuroimaging biomarkers for Friedreich\u2019s ataxia at 7\u2009tesla: susceptibility mapping, diffusion imaging, R2 and R1 relaxometry. J. Neurosci. Res. 98, 2219\u20132231 (2020).","journal-title":"J. Neurosci. Res."},{"key":"1218_CR86","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/mds.27606","volume":"34","author":"PGD Ward","year":"2019","unstructured":"Ward, P. G. D. et al. Longitudinal evaluation of iron concentration and atrophy in the dentate nuclei in Friedreich ataxia. Mov. Disord. 34, 335\u2013343 (2019).","journal-title":"Mov. Disord."},{"key":"1218_CR87","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/jnnp-2015-312665","volume":"87","author":"IH Harding","year":"2016","unstructured":"Harding, I. H. et al. Tissue atrophy and elevated iron concentration in the extrapyramidal motor system in Friedreich ataxia: the IMAGE-FRDA study. J. Neurol. Neurosurg. Psychiatry 87, 1261\u20131263 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1218_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.29261","volume":"38","author":"TJR Rezende","year":"2023","unstructured":"Rezende, T. J. R. et al. Progressive spinal cord degeneration in Friedreich\u2019s ataxia: results from ENIGMA-Ataxia. Mov. Disord. 38, 45\u201356 (2023).","journal-title":"Mov. Disord."},{"key":"1218_CR89","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1007\/s00415-021-10512-x","volume":"268","author":"LP Selvadurai","year":"2021","unstructured":"Selvadurai, L. P. et al. Longitudinal structural brain changes in Friedreich ataxia depend on disease severity: the IMAGE-FRDA study. J. Neurol. 268, 4178\u20134189 (2021).","journal-title":"J. Neurol."},{"key":"1218_CR90","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s00415-017-8542-8","volume":"264","author":"M Mascalchi","year":"2017","unstructured":"Mascalchi, M. et al. Lower medulla hypoplasia in Friedreich ataxia: MR imaging confirmation 140\u2009years later. J. Neurol. 264, 1526\u20131528 (2017).","journal-title":"J. Neurol."},{"key":"1218_CR91","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1118\/1.3157109","volume":"36","author":"X Zhong","year":"2009","unstructured":"Zhong, X. et al. Tracking brain motion during the cardiac cycle using spiral cine-DENSE MRI. Med. Phys. 36, 3413\u20133419 (2009).","journal-title":"Med. Phys."},{"key":"1218_CR92","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mds.29648","volume":"39","author":"L Fernandez","year":"2024","unstructured":"Fernandez, L. et al. Free-water imaging in Friedreich ataxia using multi-compartment models. Mov. Disord. 39, 370\u2013379 (2024).","journal-title":"Mov. Disord."},{"key":"1218_CR93","doi-asserted-by":"publisher","first-page":"fcac007","DOI":"10.1093\/braincomms\/fcac007","volume":"4","author":"IH Harding","year":"2022","unstructured":"Harding, I. H. & Ward, P. G. D. Brain susceptibility imaging provides valuable in vivo insights into cerebellar diseases, but biological interpretations remain elusive. Brain Commun. 4, fcac007 (2022).","journal-title":"Brain Commun."},{"key":"1218_CR94","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200034","volume":"8","author":"M Pandolfo","year":"2022","unstructured":"Pandolfo, M. et al. Efficacy and safety of leriglitazone in patients with Friedreich ataxia: a phase 2 double-blind, randomized controlled trial (FRAMES). Neurol. Genet. 8, e200034 (2022).","journal-title":"Neurol. Genet."},{"key":"1218_CR95","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/ana.27237","volume":"98","author":"N Georgiou-Karistianis","year":"2025","unstructured":"Georgiou-Karistianis, N. et al. Neuroimaging biomarkers for Friedreich ataxia: a cross-sectional analysis of the TRACK-FA study. Ann. Neurol. 98, 386\u2013397 (2025).","journal-title":"Ann. Neurol."},{"key":"1218_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269649","volume":"17","author":"N Georgiou-Karistianis","year":"2022","unstructured":"Georgiou-Karistianis, N. et al. A natural history study to track brain and spinal cord changes in individuals with Friedreich\u2019s ataxia: TRACK-FA study protocol. PLoS ONE 17, e0269649 (2022).","journal-title":"PLoS ONE"},{"key":"1218_CR97","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.nbd.2014.11.011","volume":"74","author":"G \u00d6z","year":"2015","unstructured":"\u00d6z, G. et al. Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology. Neurobiol. Dis. 74, 158\u2013166 (2015).","journal-title":"Neurobiol. Dis."},{"key":"1218_CR98","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.expneurol.2011.09.021","volume":"232","author":"G \u00d6z","year":"2011","unstructured":"\u00d6z, G. et al. In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice. Exp. Neurol. 232, 290\u2013298 (2011).","journal-title":"Exp. Neurol."},{"key":"1218_CR99","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ana.26713","volume":"94","author":"HS McLoughlin","year":"2023","unstructured":"McLoughlin, H. S. et al. ASO silencing reverses abnormal neurochemistry in spinocerebellar ataxia 3 mice. Ann. Neurol. 94, 658\u2013671 (2023).","journal-title":"Ann. Neurol."},{"key":"1218_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1363","volume":"9","author":"TJR Rezende","year":"2019","unstructured":"Rezende, T. J. R. et al. Test\u2013retest reproducibility of a multi-atlas automated segmentation tool on multimodality brain MRI. Brain Behav. 9, e01363 (2019).","journal-title":"Brain Behav."},{"key":"1218_CR101","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mrm.26022","volume":"76","author":"M Terpstra","year":"2016","unstructured":"Terpstra, M. et al. Test\u2013retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3\u2009T and 7\u2009T. Magn. Reson. Med. 76, 1083\u20131091 (2016).","journal-title":"Magn. Reson. Med."},{"key":"1218_CR102","unstructured":"World Health Organization. Medical devices: magnetic resonance imaging units (per million population), total density. WHO https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/total-density-per-million-population-magnetic-resonance-imaging (2026)."},{"key":"1218_CR103","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fneur.2020.00902","volume":"11","author":"CC Lin","year":"2020","unstructured":"Lin, C. C., Ashizawa, T. & Kuo, S. H. Collaborative efforts for spinocerebellar ataxia research in the United States: CRC-SCA and READISCA. Front. Neurol. 11, 902 (2020).","journal-title":"Front. Neurol."},{"key":"1218_CR104","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12311-025-01885-0","volume":"24","author":"Y Lin","year":"2025","unstructured":"Lin, Y. et al. The natural history study and biomarker collection of the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA). Cerebellum 24, 134 (2025).","journal-title":"Cerebellum"},{"key":"1218_CR105","unstructured":"Ataxia Global Initiative. Projects. Ataxia Global Initiative https:\/\/ataxia-global-initiative.net\/projects\/ (2026)."},{"key":"1218_CR106","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/mds.23067","volume":"25","author":"G \u00d6z","year":"2010","unstructured":"\u00d6z, G. et al. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov. Disord. 25, 1253\u20131261 (2010).","journal-title":"Mov. Disord."},{"key":"1218_CR107","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuroimage.2008.06.036","volume":"43","author":"R Della Nave","year":"2008","unstructured":"Della Nave, R. et al. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. Neuroimage 43, 10\u201319 (2008).","journal-title":"Neuroimage"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01218-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01218-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01218-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:03:16Z","timestamp":1782993796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01218-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":107,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01218-7","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"1 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.\u00d6. has consulted for IXICO Technologies, Lacerta Therapeutics, Servier and UCB Biopharma; has served on the Scientific Advisory Board of BrainSpec and the Medical Research Advisory Board of the National Ataxia Foundation; and has received research support from Biogen. S.C. has consulted for TTLC; has served on the Scientific Advisory Board of Amicus Therapeutics; and has received research grants from Fondazione Italiana Sclerosi Multipla and Telethon. T.J.R.R. has consulted for and received research support from Biogen and PTC Therapeutics. P.-G.H. has received research support from Minoryx Therapeutics. J.F. has received consultancy honoraria from Vico Therapeutics, unrelated to the present manuscript. I.H.H. has consulted for Solid Biosciences and Steminent Biotherapeutics in the 12\u2009months preceding manuscript submission.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}